- Home
- CRNX vs QFIN Comparison
CRNX vs QFIN Comparison
Compare CRNX & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- QFIN
- Stock Information
- Founded
- CRNX 2008
- QFIN 2016
- Country
- CRNX United States
- QFIN China
- Employees
- CRNX N/A
- QFIN N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- QFIN Finance: Consumer Services
- Sector
- CRNX Health Care
- QFIN Finance
- Exchange
- CRNX Nasdaq
- QFIN Nasdaq
- Market Cap
- CRNX 5.2B
- QFIN 5.6B
- IPO Year
- CRNX 2018
- QFIN 2018
- Fundamental
- Price
- CRNX $37.35
- QFIN $38.37
- Analyst Decision
- CRNX Strong Buy
- QFIN Strong Buy
- Analyst Count
- CRNX 10
- QFIN 1
- Target Price
- CRNX $74.40
- QFIN $37.50
- AVG Volume (30 Days)
- CRNX 1.0M
- QFIN 940.1K
- Earning Date
- CRNX 02-26-2025
- QFIN 03-11-2025
- Dividend Yield
- CRNX N/A
- QFIN 3.08%
- EPS Growth
- CRNX N/A
- QFIN 42.14
- EPS
- CRNX N/A
- QFIN 4.99
- Revenue
- CRNX $1,038,999.00
- QFIN $2,449,056,522.00
- Revenue This Year
- CRNX N/A
- QFIN $6.26
- Revenue Next Year
- CRNX $195.21
- QFIN $3.96
- P/E Ratio
- CRNX N/A
- QFIN $7.69
- Revenue Growth
- CRNX N/A
- QFIN 9.41
- 52 Week Low
- CRNX $35.24
- QFIN $13.71
- 52 Week High
- CRNX $62.53
- QFIN $40.31
- Technical
- Relative Strength Index (RSI)
- CRNX 24.86
- QFIN 57.14
- Support Level
- CRNX $35.51
- QFIN $35.34
- Resistance Level
- CRNX $53.55
- QFIN $37.38
- Average True Range (ATR)
- CRNX 2.36
- QFIN 1.16
- MACD
- CRNX -1.41
- QFIN -0.15
- Stochastic Oscillator
- CRNX 10.14
- QFIN 72.14
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About QFIN Qifu Technology Inc.
Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.